Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses

Summary: SARS-CoV-2 variants evade current monoclonal antibody therapies. Bispecific antibodies (bsAbs) combine the specificities of two distinct antibodies taking advantage of the avidity and synergy provided by targeting different epitopes. Here we used controlled Fab-arm exchange to produce bsAbs...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Laura Radić, Kwinten Sliepen, Victor Yin, Mitch Brinkkemper, Joan Capella-Pujol, Angela I. Schriek, Jonathan L. Torres, Sandhya Bangaru, Judith A. Burger, Meliawati Poniman, Ilja Bontjer, Joey H. Bouhuijs, David Gideonse, Dirk Eggink, Andrew B. Ward, Albert J.R. Heck, Marit J. Van Gils, Rogier W. Sanders, Janke Schinkel
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: Elsevier 2023-04-01
Σειρά:iScience
Θέματα:
Immunology
Virology
Structural biology
Διαθέσιμο Online:http://www.sciencedirect.com/science/article/pii/S258900422300617X

Διαδίκτυο

http://www.sciencedirect.com/science/article/pii/S258900422300617X

Παρόμοια τεκμήρια